Second-Line Treatment in cholangiocarcinoma - Current State of the Art and Future Perspectives
Crossref DOI link: https://doi.org/10.1007/s11864-025-01365-x
Published Online: 2025-10-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Siwek, Michał
Chmiel, Paulina
Grabowska, Hanna
Grąt, Michał
Kraj, Leszek
Text and Data Mining valid from 2025-10-17
Version of Record valid from 2025-10-17
Article History
Received: 9 June 2025
Accepted: 30 September 2025
First Online: 17 October 2025
Declarations
:
: The authors declare no competing interests.